Why the study?
The study aimed to evaluate whether the Naples prognostic score, based on inflammatory and nutritional status, predicts decreased LVEF after acute STEMI.
Does a high Naples prognostic score predict decreased discharge LVEF and worse in-hospital outcomes in STEMI patients undergoing primary PCI?
Does a high Naples prognostic score predict decreased discharge LVEF and worse in-hospital outcomes in STEMI patients undergoing primary PCI?
The Naples prognostic score is a simple tool that predicts lower discharge LVEF and higher rates of hospital mortality, shock, and no-reflow in STEMI patients treated with primary PCI.
Answers are grounded in this paper and cite their sources.
NPS may aid STEMI risk stratification post-PCI; leaves open prospective validation before clinical adoption.
The Naples score is a new prognostic score developed according to inflammatory and nutritional status and frequently evaluated in cancer patients. The present study aimed to evaluate using the Naples prognostic score (NPS) to predict the development of decreased left ventricular ejection fraction (LVEF) after acute ST-segment elevation myocardial infarction (STEMI). The study has a multicenter and retrospective design and included 2280 patients with STEMI who underwent primary percutaneous coronary intervention (pPCI) between 2017 and 2022. All participants were divided into 2 groups according to their NPS. The relationship between these 2 groups and LVEF was evaluated. The low-Naples risk group (Group-1) included 799 patients, and the high-Naples risk group (Group-2) had 1481 patients. Hospital mortality, shock, and no-reflow rates were found to be higher in Group 2 compared with Group 1 (P < .001, P = .032, P = .004). The NPS was significantly inversely associated with discharge LVEF (B coefficient: -1.51, 95% CI-2.26; -.76, P = .001). NPS, a simple and easily calculated risk score, may help identify high-risk STEMI patients. To the best of our knowledge, the present study is the first to demonstrate the relationship between low LVEF and NPS in patients with STEMI.
No takes yet. Share an insight, caveat, or question.
Birdal et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: